AR003484A1 - Forma cristalina sustancialmente pura de la (±)-5-{[5-bis(1,1-dimetiletil) -4-hidroxifenil]-metil}-4-tiazolidinona (tazofelona) y composicionesfarmaceuticas que la contienen - Google Patents
Forma cristalina sustancialmente pura de la (±)-5-{[5-bis(1,1-dimetiletil) -4-hidroxifenil]-metil}-4-tiazolidinona (tazofelona) y composicionesfarmaceuticas que la contienenInfo
- Publication number
- AR003484A1 AR003484A1 ARP960104199A AR10419996A AR003484A1 AR 003484 A1 AR003484 A1 AR 003484A1 AR P960104199 A ARP960104199 A AR P960104199A AR 10419996 A AR10419996 A AR 10419996A AR 003484 A1 AR003484 A1 AR 003484A1
- Authority
- AR
- Argentina
- Prior art keywords
- crystalline form
- amrstrong
- bis
- pharmaceutical compositions
- tiazolidinone
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- ILMMRHUILQOQGP-UHFFFAOYSA-N 5-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-1,3-thiazolidin-4-one Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CC2C(NCS2)=O)=C1 ILMMRHUILQOQGP-UHFFFAOYSA-N 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000013016 Hypoglycemia Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229950009722 tazofelone Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US335695P | 1995-09-07 | 1995-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003484A1 true AR003484A1 (es) | 1998-08-05 |
Family
ID=21705475
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960104199A AR003484A1 (es) | 1995-09-07 | 1996-09-02 | Forma cristalina sustancialmente pura de la (±)-5-{[5-bis(1,1-dimetiletil) -4-hidroxifenil]-metil}-4-tiazolidinona (tazofelona) y composicionesfarmaceuticas que la contienen |
| ARP960104198A AR003483A1 (es) | 1995-09-07 | 1996-09-02 | Procedimiento para preparar y aislar la forma ii de la (±)-5-[3,5-bis(1,1- dimetil)-4-hidroxifenil)-metil)-4-tiazolidinona. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960104198A AR003483A1 (es) | 1995-09-07 | 1996-09-02 | Procedimiento para preparar y aislar la forma ii de la (±)-5-[3,5-bis(1,1- dimetil)-4-hidroxifenil)-metil)-4-tiazolidinona. |
Country Status (29)
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US538690A (en) * | 1895-05-07 | Automatic watering-trough for animals | ||
| US5216002A (en) * | 1989-12-21 | 1993-06-01 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
| ZA9010041B (en) * | 1989-12-21 | 1992-08-26 | Lilly Co Eli | Compounds for treating inflammatory bowel disease |
-
1996
- 1996-09-02 AR ARP960104199A patent/AR003484A1/es not_active Application Discontinuation
- 1996-09-02 PE PE1996000641A patent/PE23298A1/es not_active Application Discontinuation
- 1996-09-02 DK DK96306336T patent/DK0761656T3/da active
- 1996-09-02 AR ARP960104198A patent/AR003483A1/es not_active Application Discontinuation
- 1996-09-02 PT PT96306336T patent/PT761656E/pt unknown
- 1996-09-02 TW TW085110670A patent/TW460471B/zh active
- 1996-09-02 EP EP96306336A patent/EP0761656B1/en not_active Expired - Lifetime
- 1996-09-02 ES ES96306336T patent/ES2153081T3/es not_active Expired - Lifetime
- 1996-09-02 AT AT96306336T patent/ATE198476T1/de not_active IP Right Cessation
- 1996-09-02 IN IN1563CA1996 patent/IN182320B/en unknown
- 1996-09-02 ZA ZA9607422A patent/ZA967422B/xx unknown
- 1996-09-02 DE DE69611407T patent/DE69611407T2/de not_active Expired - Fee Related
- 1996-09-02 SI SI9630287T patent/SI0761656T1/xx unknown
- 1996-09-03 CA CA002231132A patent/CA2231132A1/en not_active Abandoned
- 1996-09-03 WO PCT/US1996/014132 patent/WO1997009320A1/en not_active Application Discontinuation
- 1996-09-03 CZ CZ98680A patent/CZ68098A3/cs unknown
- 1996-09-03 KR KR1019980701701A patent/KR19990044453A/ko not_active Withdrawn
- 1996-09-03 AU AU69127/96A patent/AU716684B2/en not_active Ceased
- 1996-09-03 TR TR1998/00398T patent/TR199800398T1/xx unknown
- 1996-09-03 JP JP9511339A patent/JPH11514978A/ja active Pending
- 1996-09-03 BR BR9610201A patent/BR9610201A/pt not_active Application Discontinuation
- 1996-09-03 HU HU9901458A patent/HUP9901458A3/hu unknown
- 1996-09-03 PL PL96325602A patent/PL325602A1/xx unknown
- 1996-09-03 EA EA199800275A patent/EA000258B1/ru not_active IP Right Cessation
- 1996-09-03 NZ NZ316810A patent/NZ316810A/xx unknown
- 1996-09-03 CN CN96197822A patent/CN1082958C/zh not_active Expired - Fee Related
- 1996-09-04 MY MYPI96003663A patent/MY132351A/en unknown
- 1996-09-05 CO CO96047346A patent/CO4750653A1/es unknown
-
1998
- 1998-03-03 NO NO980913A patent/NO309719B1/no not_active IP Right Cessation
-
2001
- 2001-03-29 GR GR20010400506T patent/GR3035656T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA84407C2 (en) | Acetyl 2-hydroxy-1,3 diaminoalkanes | |
| EP0763605A3 (en) | Cementer carbide article and master alloy composition | |
| CA2114156A1 (en) | Elucidation and Synthesis of Selected Pentapeptides | |
| AU3140093A (en) | Synthesis and optical resolution of the taxol side chain and related compounds | |
| IL117799A0 (en) | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases | |
| IL112292A (en) | Use of compounds containing 1-aminoindan and derivatives thereof for the preparation of pharmaceutical compositions | |
| CA2231971A1 (en) | Hypolipidemic 1,4-benzothiazepine-1,1-dioxides | |
| ES2160949T3 (es) | Derivados de fenilen-sulfonamida sustituidos en meta. | |
| AU1744300A (en) | Process for synthesis of allophanate compounds and compositions including the product thereof | |
| AU7498494A (en) | New bis-naphthalimides for the treatment of cancer | |
| NO940777L (no) | Anvendelse av et pregnanderivat | |
| MY114282A (en) | Anthracycline derivatives | |
| AR003484A1 (es) | Forma cristalina sustancialmente pura de la (±)-5-{[5-bis(1,1-dimetiletil) -4-hidroxifenil]-metil}-4-tiazolidinona (tazofelona) y composicionesfarmaceuticas que la contienen | |
| AU5135796A (en) | Novel intermediates for the synthesis of trifluoromethylated organic compounds | |
| BR9408195A (pt) | Conjugados de hirudina formados de uma hirudina e um ou vários compostos lipófilos e processo para a produção de conjugados de hirudina | |
| TNSN05067A1 (en) | Acetyl 2-hydroxy- 1,3 diaminoalkanes | |
| ATE120369T1 (de) | Verwendung stabiler oxapenem-3-carbonsäuren zur herstellung beta-lactamase hemmender arzneimittel. | |
| DE59307133D1 (de) | Gestagen wirksame 19,11-überbrückte 4-estrene | |
| DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
| ES8704897A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas | |
| MX9701948A (es) | Epimeros de (22rs-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa-androst-1-e n-17beta-carboxamida. | |
| PL318539A1 (en) | Inhibition of biosynthesis | |
| ID26946A (id) | Senyawa-senyawa baru | |
| ECSP961865A (es) | Forma cristalina alternativa de tazofelona (caso x - 9667) | |
| FR2721028B1 (fr) | Procédé de synthèse d'halogénoalkylferrocènes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |